Final Glance: Medical Devices companies
AP - Thu May 15, 5:15PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were down at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Thu May 15, 5:15PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were down at the close of trading:
Midday Glance: Medical Devices companies
AP - Thu May 15, 12:32PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are down at 1 p.m.:
Midday Glance: Pharmaceuticals companies
AP - Thu May 15, 12:31PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
Johnson & Johnson Has Returned 11.3% Since SmarTrend Recommendation (JNJ)
Comtex SmarTrend(R) - Thu May 15, 11:18AM CDT
SmarTrend identified an Uptrend for Johnson & Johnson (NYSE:JNJ) on February 10th, 2014 at $90.44. In approximately 3 months, Johnson & Johnson has returned 11.31% as of today's recent price of $100.67.
Research and Markets: Asia Pacific Facial Care Market 2013-2019 - Industry Analysis, Size, Share, Growth, Trends, and Forecasts
Business Wire - Thu May 15, 9:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ldj749/facial_care) has announced the addition of the "Facial Care Market - Asia-Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019" report to their offering.
Early Glance: Pharmaceuticals companies
AP - Thu May 15, 9:34AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 10 a.m.:
Early Glance: Medical Devices companies
AP - Thu May 15, 9:34AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Asia Pacific Facial Care Market 2013-2019 - Industry Analysis, Size, Share, Growth, Trends, and Forecasts
M2 - Thu May 15, 6:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hqpwzl/facial_care) has announced the addition of the "Facial Care Market - Asia-Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019" report to their offering. Major companies included in this report are L'Oreal S.A., Kose Corporation, Kao Corporation, Johnson & Johnson Ltd., Shiseido Co. Ltd., The Procter & Gamble Company, The Unilever Plc, and Estee Lauder Companies Inc. among others. The market is segmented based on product type, consumer group, retail distribution, and countries. On the basis of product type, the market has been segmented into skin whitening/ lightening and anti-ageing, facial creams, face wash, cleansing wipes, serums and masks, and others (fade creams, pore strips and toners). Further, the consumer group segment has been sub-segmented into men and women. On the basis of retail distribution, the market is segmented into store-based retailing and non store-based retailing. Following countries are considered in the report, China, Japan, India, Indonesia, Malaysia, Hong Kong, South Korea, Thailand, and Oceania (New Zealand and Australia). This report is thereby produced to give a detailed overview of the ongoing trends in the market. It includes a review of market dynamics with focus on market drivers, growth challenges (restraints), and opportunities. The value chain analysis and Porter's five forces analysis included in the report further help in assessing the market situation and competitiveness. Market attractiveness analysis highlights key segments of the market and their comparative attractiveness against other segments. Apart from the detailed sub-segment analysis as illustrated through the figure given below, this report also provides company profiles of key market players. The competitive profiling of these players includes company and financial overview, business strategies adopted by them, SWOT analysis and their recent developments which can help in assessing competition in the market. The report segments the Asia-Pacific facial care market into following sub-segments: By Product - Skin whitening/ lightening and anti aging creams - Facial creams - Face wash - Cleansing wipes - Serums and masks - Others (fade creams, pore strips and toners) By Consumer Group - Men - Women By Retail Distribution - Store based - Non-store based By Countries - China - Japan - India - Indonesia - Malaysia - Hong Kong - South Korea - Thailand - Oceania (New Zealand and Australia) For more information visit http://www.researchandmarkets.com/research/hq...acial_care
Feminine Hygiene Products - Global Strategic Business Report 2013-2020
M2 - Thu May 15, 6:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v8j939/feminine_hygiene) has announced the addition of the "Feminine Hygiene Products - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Feminine Hygiene Products in US$ Million by the following Product Segments: Sanitary Pads/Towels, Tampons, Panty liners, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered (Partial) I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW - Hygiene Products: An Integral Part of a Woman's Life - Traditional Revenue Contributors Making Way for Asian Super Powers - Recession in Retrospect and the Road Ahead - Current State of the Economy: A Key Growth Indicator - Outlook 2. COMPETITION - A Mature Market - Competition: Noteworthy Trends - Aggressive Competition Poses Challenges - Consumer Education Continue to Remain a Core Issue - Knowing the Psychographic Profile of Consumer Vital for Success - Different Products to Suit Different Phases in Women's Life: A Rising Trend - Companies Offer Multi-Purpose Products to Augment Sales - Manufacturers Work with Charitable Organizations to Promote Sanitary Protection Products - Manufacturers Unmoved by Rising Raw Material Costs - Design and Brand Innovations: An Important Product Differentiator - Innovative Product and Marketing Strategies: The Sage Continues 3. MARKET TRENDS & DRIVERS - Increasing Focus on Women's Health, Comfort and Convenience: A Strong Growth Driver - Comfort Outperforms Price - The Convenience Factor - Physically Active Schedules: A Preferred Lifestyle Choice - Favorable Demographic, Social and Economic Trends Strengthens Market Prospects - Teen Population: A Lucrative Demographic Segment & the New Advertising Target - Rising Women Workforce: A Business Case for Hygiene Market - Innovative Approaches Set to Alter the Landscape - Product Advancements: Spearheading Growth - DivaCup: A Breakthrough from Conventional Tampons and Pads 4. KEY ISSUES CONFRONTING THE MARKET - Dangerous Chemicals in Feminine Health Care Products: A Rising Concern - Clean, Ultra-White Menstrual Pads and Tampons: A Threat to Women's Health? - Sustainability Issues Come to Fore - The Irony of Toxic Products & their Sanitary Protection Claims - Unraveling the Truth About Pads & Tampons - Tampon Applicators & their Impact on the Environment - What the Manufacturers Have to Say? - Toxic Shock Syndrome (TSS): Safety of Feminine Sanitary Products Questioned - Passing the Buck - Unsettling Statistics in the Past 5. PRODUCT OVERVIEW - Feminine Hygiene Products: A Definition - An Evolution Scan - Major Product Types - Applicator Tampons - Digital or Applicator-free Tampons - Cordless Tampons - How to Handle a Tampon? - Sanitary Towels - Panty liners - Definition - Menstrual Cups - Accessories in Female Hygiene 6. PRODUCT INNOVATIONS/INTRODUCTIONS - Unicharm to Launch Hygiene Products in Asia, Middle East and African Regions - Soothe Healthcare to Introduce New Line of Sanitary Napkins - Procter & Gamble Launches Always Platinum - Tampax to Launch Gender Neutral Tampons - Kimberly-Clark Launches U by Kotex Extra Pads - StressNoMore Introduces Natural Sea-sponge Tampons by Jade & Pearl Sea Pearls - AdvaCare Introduces Female Sanitary Pads and Colostomy Bags - The Urology Comparil Introduces Evofem's Softcup - Tamicare Introduces New Technology for Feminine Hygiene Market 7. RECENT INDUSTRY ACTIVITY - Energizer Acquires Johnson & Johnson's Feminine Hygiene Business - Unicharm Completes Takeover of CFA International Paper Products - Kimberley-Clark to Expand Footprint in Indian Feminine Care and Babycare Market - Domtar to Acquire Laboratorios Indas - Ontex Establishes Manufacturing Plant in Karachi - Diana Commences Construction of Manufacturing Plant in Vietnam - SCA Enters into Contract with Sogeti - SCA to Invest in Hygiene Products - Tamicare to Shift Production to its New Plant - Domtar Acquires EAM - P&G Acquires Stake in Arbora & Ausonia JV from Agrolimen Group - Top Image Systems Signs Contract with Fater 8. FOCUS ON SELECT GLOBAL PLAYERS - Albaad Corporate (Israel) - Rostam Ltd. (Israel) - Energizer Holdings Inc. (USA) - Johnson & Johnson (USA) - Playtex Products Inc. (USA) - Kao Corporation (Japan) - Kimberly-Clark Corporation (USA) - Lil-lets Group Limited (UK) - Natracare Bodywise (UK) Ltd. (UK) - PayChest, Inc. (USA) - Procter & Gamble (USA) - Svenska Cellulosa Aktiebolaget (SCA) (Sweden) - Unicharm Corporation (Japan) 9. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. LATIN AMERICA 7. REST OF WORLD IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 95 (including Divisions/Subsidiaries 129) - The United States (14) - Canada (3) - Japan (5) - Europe (58) - France (5) - Germany (5) - The United Kingdom (6) - Italy (9) - Spain (3) - Rest of Europe (30) - Asia-Pacific (Excluding Japan) (36) - Latin America (1) - Middle-East (10) - Africa (2) For more information visit http://www.researchandmarkets.com/research/v8...ne_hygiene
Point of Care Diagnostic Testing: World Markets - Updated 2014 Report (Includes 107 Company Profiles)
M2 - Thu May 15, 6:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nzmpts/point_of_care) has announced the addition of the "Point of Care Diagnostic Testing: World Markets" report to their offering. Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening. Key Topics Covered: 1. Overview 2. Overview of Diagnostic Testing Point of Care Markets 3. Summary Analysis of the Global POCT Market: Value, Growth Rates and Market Share 4. Analysis of the U.S. POCT Market: Value, Growth Rates and Market Share 5. Analysis of the European POCT Market: Value, Growth Rates and Market Shares 6. Analysis of the POCT Markets for Japan, China and India: Value, Growth Rates and Market Share 7. Analysis of the Rest of World (ROW) POCT Market: Value, Growth Rates and Market Share 8. Review of the Market Segments, Reagents and Equipment 9. POCT: Growth Regulators 10. Business Trends in the POC Sector 11. Technology Platform Innovations in POCT 12. Data Management and Connectivity 13. Corporate Profiles 14. POCT Sector Trends and Forecasts 15. New Entrants to the Point of Care Market Companies Mentioned: - A. Menarini Diagnostics - ACON Laboratories, Inc. - Abaxis, Inc. - Abbott Laboratories - AccuBioTech Co., Ltd. - AccuTech, LLC - Accumetrics, Inc. (Accriva Diagnostics) - Beckman Coulter (Danaher Corporation) - BiOracle - Bio-Rad Laboratories, Inc. - BioLytical Laboratories - BioScan Screening Systems, Inc. - BioSite - Biomerica, Inc. - Calmark Sweden AB - s) - IND Diagnostic - Instrumentation Laboratory (IL)/Werfen Group - International Technidyne Corporation (ITC) - Jant Pharmacal Corporation - Johnson & Johnson - Lein Applied Diagnostics - Siloam Biosciences, Inc. - Spectral Diagnostics, Inc. - StatSure Diagnostic Systems, Inc. - Step Detect Associates, LLC - Strategic Diagnostics, Inc. - Techne Corporation - Telcare - Trinity Biotech Plc For more information visit http://www.researchandmarkets.com/research/nz...nt_of_care
Global mHealth Market Report 2012-2020: Key Forecasts for the $58 Billion Industry
M2 - Thu May 15, 2:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dxwc6k/mhealth_market) has announced the addition of the "Global mHealth Market Report Forecasts Report, 2020" report to their offering. Increasing number of active subscribers and growing coverage of mobile networks is primarily driving the demand for smart and connected devices, which in turn is steering the growth of Mobile Healthcare Market. On top of that, increase in incidence of lifestyle driven diseases, namely diabetes and obesity, which is enabling the mobile healthcare devices market growth. In spite of technological advancement in medical devices and rise in per capita income, the higher cost of healthcare systems poses challenges such as affordability and complexity worldwide. In developed markets, due to rise in chronic diseases, per capita expenditure on healthcare is increasing at a faster rate than increase in income level and inflation rate. Yet, there has been no corresponding increase in quality of healthcare services rendered in many countries, thus can be treated as an opportunity for Mobile Health Market. On the other hand, developing countries are still struggling to provide adequate healthcare solutions to their citizens. Owing to factors detailed above, the global mobile health (mHealth) market is estimated to reach $58.8 billion by the end of 2020 at a CAGR of 32.3% between 2013 and 2020. Blood Glucose Meters market is projected to lead the mHealth devices market followed by cardiac monitoring devices during the forecast period (2013 - 2020). Increasing emphasis on preventive medication is expected to drive the mHealth service market. Monitoring services is expected to take away major chunk of the market with most of the revenue coming from the developed regions. Europe leads the regional market landscape of the global mHealth market followed by Asia Pacific and North America. Furthermore, by 2020, Asia Pacific will take away the lead from North America, occupying more than 28.2% of the market. The players profiled in this report include: Philips healthcare, Omron HealthCare Inc., Bayer Healthcare, LifeWatch, Cardionet Inc., Masimo Corporation, Sanofie, Boston Scientific, AT&T Inc., and Johnson & Johnson. KEY BENEFITS - This report identifies and analyzes factors that accelerate the market growth driven by increase in lifestyle diseases, integration of wireless technologies with portable healthcare devices, technological innovations, cost and convenience factors and government initiatives - Report analyzes 2012 market and forecasts demand for mHealth market through 2020. The report is segmented by mobile compatible monitoring devices, mHealth services, stakeholders, therapeutic area and geographic regions - Competitive analysis to effectively plan and execute business plan - Identification of key application segments based on future potential and growth prospects - Identification of key players and their business performance analysis based on strategies followed by them - Top factors that are expected to affect the growth of the market along with impact analysis of every such factor - Examine the challenges that must be addressed and overcome in the mHealth market to achieve fiscal success throughout the mHealth market - Report provides regulatory framework regulates introduction of new mobile compatible medical devices - Analysis of the market factors in various geographic regions and help understand business opportunities KEY MARKET SEGMENTS GLOBAL MARKET - BY EQUIPMENT - Blood Glucose Meters - BP Monitors - Pulse Oximeters - Neurological Monitoring - Cardiac Monitors - Apnea & Sleep Monitor - Wearable fitness sensor device and Heart Rate Meters - Others GLOBAL MARKET - BY SERVICE - Wellness Services Market - Prevention Services Market - Treatment Services Market - Diagnosis Service Market - Monitoring Services Market - Healthcare Systems Strengthening Solutions Market GLOBAL MARKET - BY STAKEHOLDERS - Mobile Operators - Device Vendors - Healthcare Providers - Application Players GLOBAL MARKET - BY THERAPEUTIC SEGMENT - Cardiovascular - Diabetes - Respiratory - Neurology - Others KEY AUDIENCES - Medical Devices Manufacturers - Telecommunications Services Providers - Research Institutions - Healthcare Institutions - Content/Application Players Companies Mentioned - AT&T Inc. - Bayer Healthcare - Boston Scientific - Cardionet Inc. - Johnson & Johnson - LifeWatch - Masimo Corporation - Omron HealthCare Inc. - Philips healthcare - Sanofie For more information visit http://www.researchandmarkets.com/research/dx...lth_market
Jim Cramer's 'Mad Money' Recap: American Consumers Are Still Afraid
at The Street - Wed May 14, 7:19PM CDT
The Great Recession of 2008 has had a continued impact on our society, Cramer says.
ASCO '14 Preview: Blood Cancer Data from Pharmacyclics, Gilead, Abbvie
at The Street - Wed May 14, 4:00PM CDT
All three companies will be presented updates results on drugs used to treat chronic lymphocytic leukemia.
Is Johnson & Johnson Still a Good Bet?
Joseph Gacinga, The Motley Fool - Motley Fool - Wed May 14, 1:00PM CDT
Most investors looking to cash in on new drugs have usually gravitated toward biotech stocks. But Johnson & Johnson has historically delivered its fair share of winners that have fuelled healthy profit growth for the health-care giant. With a...
Critical Alerts For AT&T, Johnson and Johnson, Finisar, Rackspace Hosting, and Netflix Released By InvestorsObserver
PR Newswire - Wed May 14, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for T, JNJ, FNSR, RAX, and NFLX.
Janssen Labs Expanding and Accelerating Coast to Coast -- Unveils Plan to Enhance the Innovation Ecosystem with New Incubator in South San Francisco and Awards One Year of Lab Space to Three Innovative Healthcare Companies in Boston
PR Newswire - Wed May 14, 7:00AM CDT
Janssen Labs, part of Janssen Research & Development, LLC (Janssen), today announced plans to open Janssen Labs @South San Francisco, a new 30,000-square foot, standalone operation based at 329 Oyster Point Boulevard, South San Francisco, CA. The new location will accommodate up to 50 independent, emerging companies to be co-located with staff from Johnson & Johnson Innovation, LLC. Like the successful flagship Janssen Labs in San Diego, Janssen Labs @South San Francisco will include a combination of shared and private lab and office spaces and feature value-added solutions including operational support, education and business services. Janssen Labs @South San Francisco is scheduled to open at the end of the year.
Endovascular Aneurysm Repair Market Report 2014 - Concise Analysis of the $3 Billion Industry
M2 - Wed May 14, 6:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gm6gwp/endovascular) has announced the addition of the "Endovascular Aneurysm Repair Market" report to their offering. Industry boundaries are imaginary lines arbitrarily drawn along technologies, markets and target customer lines to aid analysis needs of planners and strategists operating within the defined segment. The market for endovascular aneurysm repair, regardless of location, lends itself readily to such a definition of a well defined market that has already exceeded $3 billion in annual revenue and is well on its way to achieve $5 billion in annual sales before the end of 2020. Capitalizing on recent research on the endothelial homeostasis hypothesis of aneurysm initiation, progression and rupture, Medtech Ventures' analysts have developed a unique new way of looking at the endovascular aneurysm repair market that allows strategists to devise new ways of expanding their product lines, fortify their market positions, acquire relevant innovative start-ups and expand the total size of the pie for all involved. With heightened acquisition activity, the endovascular aneurysm repair market is already consolidating at a breakneck speed, however with the recent successful IPOs of TriVascular (NASDAQ:TRIV) and Lombard Medical (NASDAQ:EVAR) the market is gearing for a new dynamic phase. The Endovascular Aneurysm Repair report, which is targeted at senior executives, explores the landscape of an expanded space that encompass aortic, cerebral and peripheral aneurysms. The report maps the competitive landscape in the newly envisioned market space, profiles leading companies strategic positions as well as innovative start-up offerings. It also volunteers suggestions towards high value chain consolidation scenarios beneficial to all. Recent acquisition deals and IPO activities are profiled and valuation metrics are provided for the brave heart among stakeholders who wish to continue with the acquisition spree to further consolidate this potentially lucrative high stakes market and to set the research and development agenda for a new generation of products that could bridge both the medical device and the biotech realms. Key Topics Covered: 1. Global Endovascular Aneurysm Repair Market Analysis 2. Anatomical Segmentation 2.1 Global Aortic Endovascular Aneurysm Repair Market 2.2 Global Cerebral Endovascular Aneurysm Repair Market 2.3 Global Peripheral Endovascular Aneurysm Repair Market 3. Leading Companies Strategic Positions & Device Offerings 3.1 Medtronic 3.2 Gore 3.3 Cook 3.4 Stryker 3.5 Covidien 3.6 Terumo 3.7 Johnson & Johnson 3.8 Endologix 3.9 TriVascular 4. Leading Companies Market Shares 5. Recent Acquisitions & Future Acquisition Opportunities 5.1 Recent Acquisitions in the Space & Their Valuation Metrics 5.2 Recent IPOs in the Space & Their Current Valuations 5.3 Innovative Startups & Their Technologies 5.4 Potentially Synergistic Future Acquisition Deals 6. Geographic Segmentation 6.1 US Endovascular Aneurysm Repair Market 6.2 European Endovascular Aneurysm Repair Market 6.3 Japanese Endovascular Aneurysm Repair Market 6.4 Chinese Endovascular Aneurysm Repair Market 6.5 Latin America Endovascular Aneurysm Repair Market 7. Technology Update 7.1 Endothelial Homeostasis Hypothesis 7.2 Hemodynamic Modulation Technology 7.3 Novel Biological Therapeutic Targets 7.4 Current Status of Endovascular Aortic Aneurysm Repair 7.5 Current Status of Endovascular Cerebral Aneurysm Repair 7.6 Current Status of Endovascular Peripheral Aneurysm Repair 8. Endovascular Aneurysm Repair Market Forecast For more information visit http://www.researchandmarkets.com/research/gm...dovascular
Glucose Intolerance Clinical Trials Review 2014
M2 - Wed May 14, 6:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nxjs95/glucose) has announced the addition of the "Glucose Intolerance Global Clinical Trials Review, H1, 2014" report to their offering. Glucose Intolerance Global Clinical Trials Review, H1, 2014" provides data on the Glucose Intolerance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Glucose Intolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Glucose Intolerance. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Espy the commercial landscape of the major Universities / Institutes / Hospitals & Companies - Merck & Co., Inc. - Genfit SA - Novartis AG - N-Gene Research Laboratories, Inc. - Laboratoires Stella SA - Johnson & Johnson - Yale University - The National Institute of Diabetes and Digestive and Kidney Diseases - Hadassah Medical Organization - Maastricht University Medical Center - University of Oslo - Eunice Kennedy Shriver National Institute of Child Health and Human Development - Universite de Sherbrooke - Academic Medical Center - University of Tasmania - Chinese University of Hong Kong For more information visit http://www.researchandmarkets.com/research/nxjs95/glucose
Research and Markets: sfRowasa (Ulcerative Colitis) - Forecast and Market Analysis to 2022
Business Wire - Wed May 14, 5:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bgbnwv/sfrowasa) has announced the addition of the "sfRowasa (Ulcerative Colitis) - Forecast and Market Analysis to 2022" report to their offering.